| Assessing cardiovascular risk factors and selecting agents to successfully treat patients with type 2 diabetes mellitus. | |
| | |
MedLine Citation:
|
PMID: 21813732 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Type 2 diabetes mellitus (T2DM), obesity, and cardiovascular disease (CVD) share a common pathogenic mechanism. The prevalence of each of these conditions is increasing at an alarming rate. Despite the availability of several treatment options for patients with T2DM and the use of intensive regimens combining several antidiabetic drugs, less than half of all patients reach a target glycosylated hemoglobin level of less than 7%. Given the rapid increase in the number of patients with T2DM and obesity, as well as the CVD morbidity and mortality associated with this burden, efforts must be made to change the course of disease. The author reviews clinical trial data on the effect of glucose control on CVD risk, the selection and timing of antihyperglycemic agents, the management of associated CVD risk factors, and strategies to improve patient adherence and acceptance-with the goal of assisting physicians in selecting appropriate management strategies for their patients with T2DM. |
| | |
Authors:
|
Mark D Baldwin |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Journal of the American Osteopathic Association Volume: 111 ISSN: 1945-1997 ISO Abbreviation: J Am Osteopath Assoc Publication Date: 2011 Jul |
Date Detail:
|
Created Date: 2011-08-04 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7503065 Medline TA: J Am Osteopath Assoc Country: United States |
Other Details:
|
Languages: eng Pagination: S2-S12 Citation Subset: IM |
Affiliation:
|
FACOI, Dublin Medical Clinic II, 6350 Frantz Rd, Suite E, Dublin, Ohio 43017-1382. mdb51@earthlink.net. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Insulin therapy for management of type 2 diabetes mellitus: strategies for initiation and long-term ...
Next Document: Novel incretin-based agents and practical regimens to meet needs and treatment goals of patients wit...